WKN: | A14SSK |
ISIN: | US5288723027 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Lexicon Pharmaceuticals-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 01. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2015 | 5,03 | 12,21 | 142,74% |
2 | 2012 | 6,10 | 10,05 | 64,75% |
3 | 2009 | 5,81 | 8,12 | 39,76% |
4 | 2021 | 2,80 | 3,62 | 29,29% |
5 | 2025 | 0,75 | 0,95 | 26,67% |
6 | 2003 | 31,15 | 35,98 | 15,51% |
7 | 2016 | 12,21 | 13,38 | 9,58% |
8 | 2004 | 35,98 | 39,41 | 9,53% |
9 | 2010 | 8,12 | 7,92 | -2,46% |
10 | 2006 | 20,86 | 18,97 | -9,06% |
11 | 2013 | 10,05 | 9,09 | -9,55% |
12 | 2001 | 105,00 | 87,50 | -16,67% |
13 | 2023 | 1,77 | 1,41 | -20,34% |
14 | 2011 | 7,92 | 6,10 | -22,98% |
15 | 2020 | 3,74 | 2,80 | -25,13% |
16 | 2007 | 18,97 | 14,00 | -26,20% |
17 | 2019 | 5,44 | 3,74 | -31,25% |
18 | 2017 | 13,38 | 8,56 | -36,02% |
19 | 2018 | 8,56 | 5,44 | -36,45% |
20 | 2014 | 9,09 | 5,03 | -44,66% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2002 | 87,50 | 31,15 | -64,40% |
2 | 2008 | 14,00 | 5,81 | -58,50% |
3 | 2022 | 3,62 | 1,77 | -51,11% |
4 | 2005 | 39,41 | 20,86 | -47,07% |
5 | 2024 | 1,41 | 0,75 | -46,81% |
6 | 2014 | 9,09 | 5,03 | -44,66% |
7 | 2018 | 8,56 | 5,44 | -36,45% |
8 | 2017 | 13,38 | 8,56 | -36,02% |
9 | 2019 | 5,44 | 3,74 | -31,25% |
10 | 2007 | 18,97 | 14,00 | -26,20% |
11 | 2020 | 3,74 | 2,80 | -25,13% |
12 | 2011 | 7,92 | 6,10 | -22,98% |
13 | 2023 | 1,77 | 1,41 | -20,34% |
14 | 2001 | 105,00 | 87,50 | -16,67% |
15 | 2013 | 10,05 | 9,09 | -9,55% |
16 | 2006 | 20,86 | 18,97 | -9,06% |
17 | 2010 | 8,12 | 7,92 | -2,46% |
18 | 2004 | 35,98 | 39,41 | 9,53% |
19 | 2016 | 12,21 | 13,38 | 9,58% |
20 | 2003 | 31,15 | 35,98 | 15,51% |